Cite
Ipilimumab-Induced Hepatitis C Viral Suppression
MLA
Keisuke Shirai, et al. “Ipilimumab-Induced Hepatitis C Viral Suppression.” Journal of Clinical Oncology, vol. 31, July 2013, pp. e307–08. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3dc47c6329258dceae47779fcc0bde0d&authtype=sso&custid=ns315887.
APA
Keisuke Shirai, Steven Minter, & Ira Willner. (2013). Ipilimumab-Induced Hepatitis C Viral Suppression. Journal of Clinical Oncology, 31, e307–e308.
Chicago
Keisuke Shirai, Steven Minter, and Ira Willner. 2013. “Ipilimumab-Induced Hepatitis C Viral Suppression.” Journal of Clinical Oncology 31 (July): e307–8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3dc47c6329258dceae47779fcc0bde0d&authtype=sso&custid=ns315887.